{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:15:23Z","timestamp":1790176523425,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10654-024-01177-7","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T20:23:07Z","timestamp":1733862187000},"page":"1325-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of congenital malformations and miscarriages following maternal use of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Mathilde","family":"Latour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vauzelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Joseph-Delaffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Dechartres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","volume":"12","author":"KW Brammer","year":"1990","unstructured":"Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Clin Infect Dis. 1990;12:S318\u201326.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1177_CR2","first-page":"554","volume":"29","author":"S Chaube","year":"1969","unstructured":"Chaube S, Murphy ML. The teratogenic effects of 5-fluorocytosine in the rat. Cancer Res. 1969;29(3):554\u20137.","journal-title":"Cancer Res"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/bdra.10022","volume":"67","author":"E Menegola","year":"2003","unstructured":"Menegola E, Broccia ML, Di Renzo F, Giavini E. Pathogenic pathways in fluconazole-induced branchial arch malformations. Birth Defects Res A. 2003;67:116\u201324.","journal-title":"Birth Defects Res A"},{"key":"1177_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/bdra.20189","volume":"73","author":"E Lopez-Rangel","year":"2005","unstructured":"Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol. 2005;73:919\u201323.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/00006454-199211120-00017","volume":"11","author":"BE Lee","year":"1992","unstructured":"Lee BE, Feinberg M, Abraham JJ, Murthy AR. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J. 1992;11:1062\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S","volume":"72","author":"KA Aleck","year":"1997","unstructured":"Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet. 1997;72:253\u20136.","journal-title":"Am J Med Genet"},{"key":"1177_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","volume":"22","author":"TJ Pursley","year":"1996","unstructured":"Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis. 1996;22:336\u201340.","journal-title":"Clin Infect Dis"},{"key":"1177_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1494","volume":"369","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Straub L, et al. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ. 2020;369: m1494.","journal-title":"BMJ"},{"key":"1177_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li L, Lv Q, Yan L, Wang Y, Jiang Y. The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol. 2019;10:691.","journal-title":"Front Microbiol"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.reprotox.2015.02.009","volume":"52","author":"AMS Alsaad","year":"2015","unstructured":"Alsaad AMS, Kaplan YC, Koren G. Exposure to fluconazole and risk of congenital malformations in the offspring: a systematic review and meta-analysis. Reprod Toxicol. 2015;52:78\u201382.","journal-title":"Reprod Toxicol"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/1471-0528.15913","volume":"126","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang X, Zhou Y-Y, Jiang C-M, Jiang H-Y. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG. 2019;126:1546\u201352.","journal-title":"BJOG"},{"key":"1177_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ijgo.12993","volume":"148","author":"D Liu","year":"2020","unstructured":"Liu D, Zhang C, Wu L, Zhang L, Zhang L. Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2020;148:6\u201313.","journal-title":"Int J Gynaecol Obstet"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.reprotox.2021.05.003","volume":"104","author":"B Marin","year":"2021","unstructured":"Marin B, Vauzelle C, Coulm B, Beghin D, Latour M, Tubach F, et al. Comment on \u201cmaternal use of fluconazole and congenital malformations in the progeny: a meta-analysis of the literature.\u201d Reprod Toxicol. 2021;104:168.","journal-title":"Reprod Toxicol"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.reprotox.2020.12.018","volume":"100","author":"MC Budani","year":"2021","unstructured":"Budani MC, Fensore S, Di Marzio M, Tiboni GM. Maternal use of fluconazole and congenital malformations in the progeny: a meta-analysis of the literature. Reprod Toxicol. 2021;100:42\u201351.","journal-title":"Reprod Toxicol"},{"key":"1177_CR15","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from: www.training.cochrane.org\/handbook."},{"key":"1177_CR16","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D, Group The PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. [Internet]. PLoS Med; 2009. Available from: https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"1177_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF. Meta-analysis of observational studies in epidemiology a proposal for reporting. JAMA. 2000;283:2008.","journal-title":"JAMA"},{"key":"1177_CR18","unstructured":"Latour M, Vauzelle C, Elefant E, Dechartres A, Marin B, Tubach F. Risk of congenital malformation following maternal use of oral fluconazole (low dose\/high dose) during the first trimester of pregnancy: a systematic review and meta-analysis. PROSPERO 2021 CRD42021274003 Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021274003."},{"key":"1177_CR19","volume-title":"Epidemiology","author":"L Gordis","year":"2009","unstructured":"Gordis L. Epidemiology. 4th ed. Amsterdam: Elsevier; 2009.","edition":"4"},{"key":"1177_CR20","unstructured":"EUROCAT. EUROCAT Guide 1.5: instruction for the registration of congenital anomalies. EUROCAT central registry, University of Ulster; 2022."},{"key":"1177_CR21","unstructured":"Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf M-I, Noel-Storr A, Paynter R, Rader T, Thomas J, Wieland LS. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated October 2023). Cochrane, 2023. Available from www.training.cochrane.org\/handbook."},{"key":"1177_CR22","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. The risk of bias in non-randomized studies\u2013of interventions (ROBINS-I) assessment tool."},{"key":"1177_CR23","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1503\/cmaj.180963","volume":"191","author":"A B\u00e9rard","year":"2019","unstructured":"B\u00e9rard A, Sheehy O, Zhao J-P, Gorgui J, Bernatsky S, de Moura CS, et al. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. CMAJ. 2019;191:E179\u201387.","journal-title":"CMAJ"},{"key":"1177_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1301066","volume":"369","author":"D M\u00f8lgaard-Nielsen","year":"2013","unstructured":"M\u00f8lgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013;369:830\u20139.","journal-title":"N Engl J Med"},{"key":"1177_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1407","volume":"348","author":"P Sedgwick","year":"2014","unstructured":"Sedgwick P. Relative risks versus odds ratios. BMJ. 2014;348: g1407.","journal-title":"BMJ"},{"key":"1177_CR26","doi-asserted-by":"crossref","unstructured":"George A, Stead TS, Ganti L. What\u2019s the risk: differentiating risk ratios, odds ratios, and hazard ratios? Cureus [Internet]. 2020 [cited 2024 May 27]; Available from: https:\/\/www.cureus.com\/articles\/39455-whats-the-risk-differentiating-risk-ratios-odds-ratios-and-hazard-ratios.","DOI":"10.7759\/cureus.10047"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/biom.13197","volume":"76","author":"TJ VanderWeele","year":"2020","unstructured":"VanderWeele TJ. Optimal approximate conversions of odds ratios and hazard ratios to risk ratios. Biometrics. 2020;76:746\u201352.","journal-title":"Biometrics"},{"key":"1177_CR28","volume-title":"Introduction to Meta-analysis","author":"M Borenstein","year":"2008","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to Meta-analysis. Chichester: John Wiley & Sons; 2008."},{"key":"1177_CR29","unstructured":"Higgins JPT, Eldridge S, Li T (editors). Chapter 23: Including variants on randomized trials. Section 23.3.4: How to include multiple groups from one study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org\/handbook."},{"key":"1177_CR30","unstructured":"Core Team. R: A language and environment for statistical computing. [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2023. Available from: https:\/\/www.R-project.org\/."},{"key":"1177_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"1177_CR32","unstructured":"McMaster University and Evidence Prime. GRADEpro GDT: GRADEpro Guideline Development Tool. [Internet]. 2022. Available from: gradepro.org."},{"issue":"657","key":"1177_CR33","first-page":"e1","volume":"214","author":"MM Howley","year":"2016","unstructured":"Howley MM, Carter TC, Browne ML, Romitti PA, Cunniff CM, Druschel CM, et al. Fluconazole use and birth defects in the National Birth Defects Prevention Study. Am J Obstet Gynecol. 2016;214(657):e1-9.","journal-title":"Am J Obstet Gynecol"},{"key":"1177_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1592\/phco.19.3.221.30919","volume":"19","author":"SS Jick","year":"1999","unstructured":"Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy. 1999;19:221\u20132.","journal-title":"Pharmacotherapy"},{"key":"1177_CR35","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0002-9378(96)70119-9","volume":"175","author":"P Mastroiacovo","year":"1996","unstructured":"Mastroiacovo P, Mazzone T, Botto LD, Serafini MA, Finardi A, Caramelli L, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol. 1996;175:1645\u201350.","journal-title":"Am J Obstet Gynecol"},{"key":"1177_CR36","first-page":"14","volume":"28","author":"C Dormuth","year":"2019","unstructured":"Dormuth C, Winquist B, Fisher A, Wu F, Reynier P, Dahl M, et al. Use of oral fluconazole during pregnancy and risks of spontaneous abortion, stillbirth and major congenital malformation: an international, multi-centre cohort study. Pharmacoepidemiol Drug Saf. 2019;28:14.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1177_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.2015.17844","volume":"315","author":"D M\u00f8lgaard-Nielsen","year":"2016","unstructured":"M\u00f8lgaard-Nielsen D, Svanstr\u00f6m H, Melbye M, Hviid A, Pasternak B. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016;315:58\u201367.","journal-title":"JAMA"},{"key":"1177_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1365-2125.1999.00989.x","volume":"48","author":"HT Sorensen","year":"1999","unstructured":"Sorensen HT, Nielsen GL, Olesen C, Larsen H, Steffensen FH, Sch\u00f8nheyder HC, et al. Risk of malformations and other outcomes in children exposed to fluconazole in utero. Br J Clin Pharmacol. 1999;48:234\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1177_CR39","unstructured":"The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology. Annex 2. Guidance on methods for the evaluation of medicines in pregnancy and breastfeeding. Chapter 4. Measuring maternal, pregnancy, and neonatal outcomes. Section 4.2. Safety outcomes. https:\/\/www.encepp.eu\/standards_and_guidances\/methodologicalGuideAnnex2.shtml#nine [accessed on 02.06.2024]."},{"key":"1177_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/jac\/dkn157","volume":"62","author":"M N\u00f8rgaard","year":"2008","unstructured":"N\u00f8rgaard M, Pedersen L, Gislum M, Erichsen R, S\u00f8gaard KK, Sch\u00f8nheyder HC, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother. 2008;62:172\u20136.","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-024-01177-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T01:08:36Z","timestamp":1735261716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-024-01177-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s10654-024-01177-7","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}